David Deming

Director at Phio Pharmaceuticals

Capital raised by Phio Pharmaceuticals

$2.3M+$1.4M latest round

5 Form D filings · first filed Jan 2025 · Marlborough, MA

CURRENT ROLE: Director
SECTOR: Biotech
COMPANY FILINGS: 5
TEAM ON FILE: 3
FOUNDED: —
30D INTEREST: —

Career

1 company on file

Phio PharmaceuticalsBiotech · Marlborough, MAsince Jan 2025

Director

Listed on Phio Pharmaceuticals's Form D filings

Company filings

via EDGAR · Form D for Phio Pharmaceuticals5

DateCompanyFormAmountRole on filing

Nov 4, 2025Phio PharmaceuticalsForm D+$1.4M—

Form DNov 4, 2025 · Phio Pharmaceuticals+$1.4Mnot a signer

Jul 28, 2025Phio PharmaceuticalsForm D+$232K—

Form DJul 28, 2025 · Phio Pharmaceuticals+$232Knot a signer

Jan 17, 2025Phio PharmaceuticalsForm D+$153K—

Form DJan 17, 2025 · Phio Pharmaceuticals+$153Knot a signer

Jan 15, 2025Phio PharmaceuticalsForm D+$208K—

Form DJan 15, 2025 · Phio Pharmaceuticals+$208Knot a signer

Jan 14, 2025Phio PharmaceuticalsForm D+$266K—

Form DJan 14, 2025 · Phio Pharmaceuticals+$266Knot a signer

Overview

Last filing Nov 4, 2025

David Deming is on file as Director at Phio Pharmaceuticals in Marlborough, MA. Phio Pharmaceuticals has 5 Form D filings on record, $2.3M raised in total.

Teammates

Phio Pharmaceuticals · 2

Lisa CarsonExecutive Officer Robert J. BittermanPresidentSigner

Products

Phio Pharmaceuticals · 1

PH-762Cancer immunotherapeutic

PH-762 is the flagship product candidate of Phio Pharmaceuticals, currently in clinical studies. It shows promising potential in enhancing cancer treatment by modulating immune responses to improve therapy outcomes.